Skip to main content
Premium Trial:

Request an Annual Quote

Datar Cancer Genetics Target-MRD

Datar Cancer Genetics has launched Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. The test uses both tumor-agnostic next-generation sequencing and tumor-informed, patient-customized droplet digital PCR.